We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.38B
AUM Growth
+$356M
Cap. Flow
-$95.3M
Cap. Flow %
-1.77%
Top 10 Hldgs %
22.08%
Holding
225
New
6
Increased
74
Reduced
113
Closed
13

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$41.5M
2
SLB icon
SLB Ltd
SLB
+$19.4M
3
GSK icon
GSK
GSK
+$15.1M
4
EOG icon
EOG Resources
EOG
+$10.5M
5
APA icon
APA Corp
APA
+$9M

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$80.1M
2
CELG
Celgene Corp
CELG
+$72.6M
3
BWA icon
BorgWarner
BWA
+$26.4M
4
EXPE icon
Expedia Group
EXPE
+$26.1M
5
XRAY icon
Dentsply Sirona
XRAY
+$19.3M

Sector Composition

Rank Sector Weight
1 Financials 23.04%
2 Technology 14.53%
3 Industrials 13.46%
4 Healthcare 13.02%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORBC
201
DELISTED
ORBCOMM, Inc.
ORBC
$158K ﹤0.01%
37,500
DBRG icon
202
DigitalBridge
DBRG
$2.95B
$74K ﹤0.01%
3,873
AIG icon
203
American International
AIG
$42.4B
-11,634
Closed -$648K
BP icon
204
BP
BP
$109B
-5,805
Closed -$221K
BUD icon
205
AB InBev
BUD
$165B
-2,250
Closed -$214K
D icon
206
Dominion Energy
D
$58.8B
-2,568
Closed -$208K
HPQ icon
207
HP
HPQ
$25.8B
-20,681
Closed -$391K
HWM icon
208
Howmet Aerospace
HWM
$116B
-47,497
Closed -$947K
KTB icon
209
Kontoor Brands
KTB
$4.36B
-24,799
Closed -$870K
PINC
210
DELISTED
Premier
PINC
-17,887
Closed -$517K
SDC
211
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
-11,991
Closed -$166K
AMTD
212
DELISTED
TD Ameritrade Holding Corp
AMTD
-5,315
Closed -$248K
ERN
213
DELISTED
Erin Energy Corp
ERN
-124,244
Closed
AHR
214
DELISTED
ANTHRACITE CAP INC
AHR
$0 ﹤0.01%
13,772
CELG
215
DELISTED
Celgene Corp
CELG
-731,126
Closed -$72.6M

Similar funds

Douglas Lane & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Douglas Lane & Associates held 225 positions worth $5.38B, up 7.1% from $5.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas Lane & Associates's Q4 2019 filing shows 6 new, 74 increased, 113 reduced and 13 closed positions. Its largest new stake was Elanco Animal Health: 120,472 shares worth $3.55M. The largest sale was People Inc, an estimated $80.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Douglas Lane & Associates's largest Q4 2019 buy was Elanco Animal Health: 120,472 shares worth $3.55M.
  • Douglas Lane & Associates added most to Bristol-Myers Squibb in Q4 2019, an estimated $41.5M increase.
  • Douglas Lane & Associates's biggest Q4 2019 reduction was People Inc, cutting an estimated $80.1M.
  • Douglas Lane & Associates fully exited Celgene Corp in Q4 2019, selling an estimated $72.6M.
  • Douglas Lane & Associates's ten largest holdings make up 22% of its $5.38B portfolio in Q4 2019.
  • Douglas Lane & Associates opened 6 new positions and closed 13 in Q4 2019.
  • Douglas Lane & Associates's portfolio value rose 7.1% quarter-over-quarter to $5.38B.

Based on Douglas Lane & Associates's 13F filing for Q4 2019, filed 27 Jan 2020.